Enliven Therapeutics shares owned by SG Americas Securities
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by SG Americas Securities
from 13F filings
Historical chart of SG Americas Securities investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by SG Americas Securities
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $256k | 10k | 25.57 |
| 2024-03-31 | $166k | 9.4k | 17.60 |
| 2023-12-31 | $187k | 14k | 13.85 |
| 2023-09-30 | $157k | 12k | 13.70 |